Ovarian Cancer Prognosis
Investigators at University of Groningen have published new data on ovarian cancer prognosis
Published in Women's Health Weekly, July 16th, 2009
Investigators publish new data in the report 'Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.' "P53, EGFR and HER-2/neu are the most frequently studied molecular biological parameters in epithelial ovarian cancer, but their prognostic impact is still unequivocal. We performed a meta-analysis to more precisely estimate their prognostic significance," investigators in Groningen, Netherlands report.
"Published studies that investigated the association between p53, EGFR and HER-2/neu status and survival were identified. Meta-analysis was performed using a DerSimonian-Laird model. Publication bias was investigated using...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Academy of Sleep Medicine
Poor sleep is independently associated with depression in postpartum women - American Academy of Sleep Medicine
Sleep duration is associated with variations in levels of inflammatory markers in women - American Association for Cancer Research
Metabolic factors may play a role in risk for breast cancer - JAMA and Archives Journals
Certain biomarkers may have limited benefit for predicting cardiovascular events - Journal of the National Cancer Institute
Dietary fat linked to pancreatic cancer - Journal of the National Cancer Institute
JNCI news brief: Cost-effectiveness of HPV vaccination in the Netherlands - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
